ALLOX (Allostery Exploration Technologies S.L.) is a Barcelona-based biotechnology company developing a high-throughput, experimental-first platform for the systematic discovery of allosteric drug targets. Combining high-throughput genetics, experimental biology and AI, it measures the effects of thousands of mutations in parallel to map the functional hotspots that govern protein folding and interactions, revealing allosteric, orthosteric and other regulatory sites to guide the design of selective small-molecule therapeutics against historically difficult-to-drug targets such as intracellular protein-protein interactions and transcription factors. Founded as a spin-out of the Centre for Genomic Regulation (CRG) at the Barcelona Science Park, the company is led by CEO and co-founder Júlia Domingo.
1
Round
1
Industry
3
Tags
Oct 29, 2026
Latest raise
Funding activity · 1 round
Oct 29, 2026
$10.5M
Seed
Led by Asabys Partners
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
